News

 Read more about what we are up to.

PanGenomic Health Provides Corporate Update

PanGenomic Health Provides Corporate Update

VANCOUVER, BC, March 2, 2023 /CNW/ - PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to provide a corporate update on its strategic initiatives. Acquisition of Mindleap Health Inc. In December 2022, the Company...

PanGenomic Health’s Nara Plant Library is Now Available. Nara App also Supports New FTC Regulatory Guideline for Science-Backed Information about Natural Remedy Alternatives to Pharmaceutical Drugs

PanGenomic Health’s Nara Plant Library is Now Available. Nara App also Supports New FTC Regulatory Guideline for Science-Backed Information about Natural Remedy Alternatives to Pharmaceutical Drugs

VANCOUVER, BC, Jan. 23, 2023 /CNW/ - PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce that its Nara Plant Library is available now on the Nara app as a resource to provide science-backed information about natural remedy...

PanGenomic Health’s Mindleap App to Expand

PanGenomic Health’s Mindleap App to Expand

Vancouver, British Columbia, Canada, January 16, 2023 – PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA) (FSE: LL30) is pleased to announce that its newly-acquired subsidiary, Mindleap Health Inc. ("Mindleap") will be extending its...

PanGenomic Health Retains Capital Markets Advisory Firm

PanGenomic Health Retains Capital Markets Advisory Firm

‍Vancouver, British Columbia, January 3, 2023 – PanGenomic Health Inc. ("PanGenomic" or the "Company") (CSE: NARA) is pleased to announce that Bello Capital Partners ("Bello") has been retained to provide capital markets advisory and digital marketing services...

Year End Letter to Our Shareholders

Year End Letter to Our Shareholders

DEAR SHAREHOLDERS,  As we close out our first year as a publicly-traded company, your team at PanGenomic Health is busy laying the groundwork for success in the burgeoning health technology industry.    At the core of our evidence-based health...

PanGenomic Health Appoints Maryam Marissen as CEO

PanGenomic Health Appoints Maryam Marissen as CEO

‍September 6, 2022 – Vancouver, British Columbia.  PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE:NARA) is pleased to announce that Maryam Marissen has been appointed President & CEO, effective immediately.  Vincent...

PanGenomic Health Launches Mental Health App

PanGenomic Health Launches Mental Health App

VANCOUVER, BC, March 16, 2022 – PanGenomic Health Inc. (the “Company” or “PanGenomic Health”) is pleased to announce that it has released its beta version of the Nara app that provides consumers with personalized information about natural remedy solutions to...

PanGenomic Health Corp. Completes Sale to Zetta Capital Corp.

PanGenomic Health Corp. Completes Sale to Zetta Capital Corp.

VANCOUVER, BC, November 9, 2021 – PanGenomic Health Corp. (the “Company” or “PanGenomic Health”) is pleased to announce that its shareholders have approved the sale of all of the issued and outstanding shares of the Company to Zetta Capital Corp. (“Zetta Capital”) of...